Importantly, negative or context‐dependent findings must shape use: hs‐CRP does not uniformly improve stroke prediction across populations, as shown in older community cohorts and in more recent analyses in which incremental discrimination gains were small and even inconsistent [138, 140]. The gene discussed is CRP; the disease is stroke disorder.